Is Intravenous Ketamine Better Than Intranasal Esketamine for Treating Treatment-Resistant Depression?

Prim Care Companion CNS Disord. 2024 Feb 13;26(1):23lr03607. doi: 10.4088/PCC.23lr03607.
No abstract available

MeSH terms

  • Antidepressive Agents / pharmacology
  • Antidepressive Agents / therapeutic use
  • Depression
  • Depressive Disorder, Major* / drug therapy
  • Depressive Disorder, Treatment-Resistant* / drug therapy
  • Humans
  • Ketamine* / pharmacology
  • Ketamine* / therapeutic use

Substances

  • Esketamine
  • Ketamine
  • Antidepressive Agents